Home LiteratureArticle Details
PMID: 7029225 Published · ppublish English Comparative Study Journal Article Review

Methicillin-resistant Staphylococcus aureus bacteraemia.

The Medical journal of Australia ·Vol. 2 ·No. 4 ·1981-08-22 ·Pages 191-4

McDonald M, Hurse A, Sim KN

Abstract

Twenty-eight (53%) of 53 hospital-acquired staphylococcal bacteraemias which occurred at The Royal Melbourne Hospital over a two-year period were due to methicillin-resistant Staphylococcus aureus (MRSA). Every patient with MRSA bacteraemia had a significant underlying condition predisposing to nosocomial sepsis, and each had an intravascular foreign body in situ at the time. Most were being nursed in special care areas of the hospital and had been exposed to multiple or broad-spectrum antibiotics during the month before development of bacteraemia. Patients acquiring MRSA infection should be isolated and, when the diagnosis of bacteraemia is considered, any potential primary focus should be removed. Vancomycin is the drug of choice in life-threatening MRSA infections.

MeSH Terms
Catheterization/adverse effects Cross Infection/drug therapy Humans Methicillin/pharmacology Middle Aged Neoplasms/complications Penicillin Resistance Pneumonia/complications Sepsis/drug therapy Staphylococcal Infections/drug therapy Staphylococcus aureus/drug effects Vancomycin/therapeutic use
Chemicals
Vancomycin Methicillin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
McDonald M
Hurse A
Sim K N
Article Info
Journal
The Medical journal of Australia
Abbr.
Med J Aust
ISSN
0025-729X
Published
1981-08-22
Pages
191-4
Language
English
Region
Australia
NLM ID
0400714
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com